Mateusz Knop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mateusz Knop has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Jacek Białkowski
Department of Pediatric Cardiology and Congenital Heart Defects, Medical University of Silesia, Silesian Center for Heart Diseases, Zabrze, Poland
10 shared publications - Michal Galeczka
Medical University of Silesia in Katowice, Silesian Center for Heart Diseases
9 shared publications - Roland Fiszer
Department of Pediatric Cardiology and Congenital Heart Defects, Silesian Center for Heart Diseases in Zabrze; Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
9 shared publications - Małgorzata Szkutnik
Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases, Zabrze, Poland
6 shared publications Dominika Rojczyk
Department of Pediatric Cardiology and Congenital Heart Defects, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland
4 shared publicationsRoland Fiszer
Department of Pediatric Cardiology and Congenital Heart Defects, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Silesian Center for Heart Diseases, Zabrze, Poland
4 shared publications
Latest Publications
- 26 February 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (6) , 1199-1201
Uhl’s anomaly after Glenn shunt - clinical image of a rare congenital heart defect
Uhl’s anomaly is an extremely rare congenital heart defect, with approximately 100 cases reported since its first description in 1952 by Dr Henry Uhl. Characterized by partial or complete absence of the right ventricular myocardium, it leads to progressive right ventricle dilation and right heart failure. Due to its rarity, there is no consensus regarding its surgical or medical management. We present a case of an 18-year-old male patient with Uhl’s anomaly diagnosed in early infancy, managed by palliative Glenn shunt. This report provides insight into management of this rare condition.
- 26 February 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (6) , 1199-1201
Uhl’s anomaly after Glenn shunt - clinical image of a rare congenital heart defect
Uhl’s anomaly is an extremely rare congenital heart defect, with approximately 100 cases reported since its first description in 1952 by Dr Henry Uhl. Characterized by partial or complete absence of the right ventricular myocardium, it leads to progressive right ventricle dilation and right heart failure. Due to its rarity, there is no consensus regarding its surgical or medical management. We present a case of an 18-year-old male patient with Uhl’s anomaly diagnosed in early infancy, managed by palliative Glenn shunt. This report provides insight into management of this rare condition.
- Open Access
- 22 January 2026
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 84 (5) , 648-651
Progression of cardiac remodeling in adolescents and adults with tetralogy of Fallot: Insights from serial magnetic resonance imaging
Is available in open access under Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
- 22 January 2026
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 84 (5) , 648-651
Open AccessProgression of cardiac remodeling in adolescents and adults with tetralogy of Fallot: Insights from serial magnetic resonance imaging
Is available in open access under Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
- Open Access
- 30 July 2025
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 83 (12) , 1409-1412
Life on the edge: Unoperated tetralogy of Fallot in adults — a testimony to the remarkable endurance of the heart
- 30 July 2025
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 83 (12) , 1409-1412
Open AccessLife on the edge: Unoperated tetralogy of Fallot in adults — a testimony to the remarkable endurance of the heart
- Open Access
- 29 April 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-8
Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results—Do We Have the Proper Device?
Objectives. Patent ductus arteriosus (PDA) in elderly patients is an uncommon anomaly, and the duct itself is often calcified and fragile; therefore, transcatheter closure is more difficult. The aim is to analyse periprocedural and one-year follow-up results of transcatheter closure of PDA in such patients. Methods and results. Retrospective analysis of 33 elective patients aged ≥55 years (median 63; 56–85; 29 women), in whom PDA was closed percutaneously between 2002 and 2018 in two tertiary centres. All but three patients were symptomatic, with most in NYHA II (n = 14) and III (n = 11) class; pulmonary hypertension (n = 22), arterial hypertension (n = 22), duct calcifications (n = 17), atrial fibrillation (n = 15), significant mitral regurgitation (n = 5), and decompensated renal failure (n = 2) were observed. Different devices were applied depending on PDA morphology; nitinol wire mesh occluders with symmetrical articulating discs have been the most used in recent years (n = 11). Follow-up was conducted at an outpatient clinic (28/33 patients). The procedure was successful in all patients. There was one embolisation, followed by implantation of a larger device. No major complications were noted. A small residual shunt was present in echocardiography in one patient after one year. NYHA class improved in all but two patients (with multiple comorbidities). Conclusions. Transcatheter PDA closure in elderly patients is safe and efficient with a high complete closure rate and few complications. Amplatzer duct occluder type II is an attractive device in such patients.
- 29 April 2020
- Published by Hindawi Limited in Journal of Interventional Cardiology
- Vol. 2020, 1-8
Open AccessTranscatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results—Do We Have the Proper Device?
Objectives. Patent ductus arteriosus (PDA) in elderly patients is an uncommon anomaly, and the duct itself is often calcified and fragile; therefore, transcatheter closure is more difficult. The aim is to analyse periprocedural and one-year follow-up results of transcatheter closure of PDA in such patients. Methods and results. Retrospective analysis of 33 elective patients aged ≥55 years (median 63; 56–85; 29 women), in whom PDA was closed percutaneously between 2002 and 2018 in two tertiary centres. All but three patients were symptomatic, with most in NYHA II (n = 14) and III (n = 11) class; pulmonary hypertension (n = 22), arterial hypertension (n = 22), duct calcifications (n = 17), atrial fibrillation (n = 15), significant mitral regurgitation (n = 5), and decompensated renal failure (n = 2) were observed. Different devices were applied depending on PDA morphology; nitinol wire mesh occluders with symmetrical articulating discs have been the most used in recent years (n = 11). Follow-up was conducted at an outpatient clinic (28/33 patients). The procedure was successful in all patients. There was one embolisation, followed by implantation of a larger device. No major complications were noted. A small residual shunt was present in echocardiography in one patient after one year. NYHA class improved in all but two patients (with multiple comorbidities). Conclusions. Transcatheter PDA closure in elderly patients is safe and efficient with a high complete closure rate and few complications. Amplatzer duct occluder type II is an attractive device in such patients.
- 24 January 2020
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 78 (1) , 68-70
Transcatheter closure of atrial septal defect with Chinese and Thai nitinol wire mesh occluders in adult patients
DOI: 10.33963/KP.15121, Published online: January 04, 2020, Authors: Filip Tyc, Alexander Suchodolski, Mateusz Knop, Dominika Rojczyk, Michał Gałeczka, Sebastian Smerdziński, Małgorzata Szkutnik, Jacek Białkowski, Roland Fiszer
- 24 January 2020
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 78 (1) , 68-70
Transcatheter closure of atrial septal defect with Chinese and Thai nitinol wire mesh occluders in adult patients
DOI: 10.33963/KP.15121, Published online: January 04, 2020, Authors: Filip Tyc, Alexander Suchodolski, Mateusz Knop, Dominika Rojczyk, Michał Gałeczka, Sebastian Smerdziński, Małgorzata Szkutnik, Jacek Białkowski, Roland Fiszer
- 1 October 2019
- Published by Elsevier in Journal of Cardiology
- Vol. 74 (4) , 381-387
Medium- and long-term follow-up of transcatheter closure of ruptured sinus of Valsalva aneurysm in Central Europe population
- 1 October 2019
- Published by Elsevier in Journal of Cardiology
- Vol. 74 (4) , 381-387
Medium- and long-term follow-up of transcatheter closure of ruptured sinus of Valsalva aneurysm in Central Europe population
- 22 January 2019
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 77 (1) , 53-55
Long-term effects of combined percutaneous atrial septal defect occlusion and pulmonary valvuloplasty in children < 2.5 years old
- 22 January 2019
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 77 (1) , 53-55
Long-term effects of combined percutaneous atrial septal defect occlusion and pulmonary valvuloplasty in children < 2.5 years old
- Open Access
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 15 (2) , 247-250
Successful atrial septal defect transcatheter closure in a patient with pentalogy of Cantrell and ectopia cordis
- 1 January 2019
- Published by Termedia Sp. z.o.o. in Advances in Interventional Cardiology
- Vol. 15 (2) , 247-250
Open AccessSuccessful atrial septal defect transcatheter closure in a patient with pentalogy of Cantrell and ectopia cordis
- 16 October 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (10) , 1494
Late complete atrioventricular block after hybrid perimembranous ventricular septal defect closure in a neonate
- 16 October 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (10) , 1494
Late complete atrioventricular block after hybrid perimembranous ventricular septal defect closure in a neonate
- 14 August 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (8) , 1257-1262
Transcatheter closure of atrial septal defects type 2 in children under three years of age
Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure. Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure.
- 14 August 2018
- Published by Polskie Towarzystwo Kardiologiczne in Polish Heart Journal
- Vol. 76 (8) , 1257-1262
Transcatheter closure of atrial septal defects type 2 in children under three years of age
Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure. Background: Atrial septal defect type II (ASD), according to current standards, is closed percutaneously usually after the child has reached the age of 4-5 years. There are limited data regarding such treatment in smaller infants. Aims: To evaluate feasibility, safety and efficacy of percutaneous ASD closure in children under 3 years of age. Methods: Overall group of 149 children < 3 years with hemodynamically significant ASD, who underwent effective transcatheter ASD closure in one tertiary center between 1999 and 2014 were included. Mean procedural age of treated children was 2,2 years and weight 12,5 kg. In all nitinol wire mesh devices were applied (mostly Amplatzer Septal Occluders). ASD was closed by standard technique (except few cases when left disc of implant was inserted initially into right pulmonary vein to prevent oblique position of the device). Complications related to the procedure were divided into major and minor ones. Results: There were 97 children with a single ASD and 52 with double/multiple ASD. No death, no implant embolization, and one major complications occurred during procedure and in follow-up. ASD was completely closed in all but 8 patients with double/multiple ASD. Right ventricle diameter normalization occurred in all during 1 year follow-up. In majority of the patients in follow-up an acceleration of physical development and resolution of accompanying morbidity was observed. Conclusions: Percutaneous ASD device closure can be performer safely in children below 3 years of age with low risk of complication during and after the procedure.